Althea Technologies has completed an FDA Pre-Approval Inspection (PAI) in April 2011 and has received a license to manufacture and package a commercial parenteral product for the U.S. market. The product will be filled and packaged at the company’s new commercial manufacturing facility located in San Diego, CA. This facility, the third on Althea’s campus, was constructed to accommodate the increased demand the company has experienced in both its drug product and biologics manufacturi...